|
English
|
正體中文
|
简体中文
|
總筆數 :2828138
|
|
造訪人次 :
32086284
線上人數 :
1418
教育部委託研究計畫 計畫執行:國立臺灣大學圖書館
|
|
|
"calistru p"的相關文件
顯示項目 1-3 / 3 (共1頁)
1
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2021-09-04T06:11:25Z |
Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon-based therapy: FUNDAMENTAL, a Phase II trial
|
Buti M.; Flisiak R.; JIA-HORNG KAO; Chuang W.-L.; Streinu-Cercel A.; Tabak F.; Calistru P.; Goeser T.; Rasenack J.; Horban A.; Davis G.L.; Alberti A.; Mazzella G.; Pol S.; Orsenigo R.; Brass C. |
| 臺大學術典藏 |
2018-09-10T15:24:48Z |
Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon-based therapy: FUNDAMENTAL, a Phase II trial
|
Buti, M.;Flisiak, R.;Kao, J.-H.;Chuang, W.-L.;Streinu-Cercel, A.;Tabak, F.;Calistru, P.;Goeser, T.;Rasenack, J.;Horban, A.;Davis, G.L.;Alberti, A.;Mazzella, G.;Pol, S.;Orsenigo, R.;Brass, C.; JIA-HORNG KAO |
| 國立臺灣大學 |
2012 |
ALISPORIVIR (ALV) PLUS PEG-INTERFERON/RIBAVIRIN (PR) IN HCV G1 TREATMENT-EXPERIENCED PATIENTS ACHIEVES PRIMARY ENDPOINT WITH SUPERIOR EFFICACY AT TREATMENT WEEK 12 COMPARED TO RETREATMENT WITH PR
|
Alberti, A.; Chuang, W. -L.; Flisiak, R.; Mazzella, G.; Horban, A.; Goeser, T.; Calistru, P.; Buti, M.; Davis, G.; Gong, Y.; Avila, C.; Kao, J. -H.; 高嘉宏 |
顯示項目 1-3 / 3 (共1頁)
1
每頁顯示[10|25|50]項目
|
